Benzinga | Nov 8, 2021 06:36AM EST

Matinas BioPharma Hldgs Q3 EPS $(0.03) Misses $(0.02) Estimate

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is unchanged from the same period last year.